Imed Infinity (Israel) Performance

IMED Stock   99.30  5.20  4.98%   
The company retains a Market Volatility (i.e., Beta) of -0.4, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Imed Infinity are expected to decrease at a much lower rate. During the bear market, Imed Infinity is likely to outperform the market. At this point, Imed Infinity Medical has a negative expected return of -0.37%. Please make sure to check out Imed Infinity's jensen alpha, treynor ratio, and the relationship between the standard deviation and total risk alpha , to decide if Imed Infinity Medical performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Imed Infinity Medical Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
  

Imed Infinity Relative Risk vs. Return Landscape

If you would invest  11,800  in Imed Infinity Medical Limited on August 29, 2024 and sell it today you would lose (1,870) from holding Imed Infinity Medical Limited or give up 15.85% of portfolio value over 90 days. Imed Infinity Medical Limited is generating negative expected returns and assumes 1.6102% volatility on return distribution over the 90 days horizon. Simply put, 14% of stocks are less volatile than Imed, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days trading horizon Imed Infinity is expected to under-perform the market. In addition to that, the company is 2.07 times more volatile than its market benchmark. It trades about -0.23 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.17 per unit of volatility.

Imed Infinity Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for Imed Infinity's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Imed Infinity Medical Limited, and traders can use it to determine the average amount a Imed Infinity's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.2294

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsIMED

Estimated Market Risk

 1.61
  actual daily
14
86% of assets are more volatile

Expected Return

 -0.37
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.23
  actual daily
0
Most of other assets perform better
Based on monthly moving average Imed Infinity is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Imed Infinity by adding Imed Infinity to a well-diversified portfolio.

Imed Infinity Fundamentals Growth

Imed Stock prices reflect investors' perceptions of the future prospects and financial health of Imed Infinity, and Imed Infinity fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Imed Stock performance.

About Imed Infinity Performance

By analyzing Imed Infinity's fundamental ratios, stakeholders can gain valuable insights into Imed Infinity's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Imed Infinity has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Imed Infinity has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.

Things to note about Imed Infinity Medical performance evaluation

Checking the ongoing alerts about Imed Infinity for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Imed Infinity Medical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Imed Infinity generated a negative expected return over the last 90 days
About 21.0% of the company shares are held by company insiders
Evaluating Imed Infinity's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Imed Infinity's stock performance include:
  • Analyzing Imed Infinity's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Imed Infinity's stock is overvalued or undervalued compared to its peers.
  • Examining Imed Infinity's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Imed Infinity's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Imed Infinity's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Imed Infinity's stock. These opinions can provide insight into Imed Infinity's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Imed Infinity's stock performance is not an exact science, and many factors can impact Imed Infinity's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for Imed Stock analysis

When running Imed Infinity's price analysis, check to measure Imed Infinity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imed Infinity is operating at the current time. Most of Imed Infinity's value examination focuses on studying past and present price action to predict the probability of Imed Infinity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imed Infinity's price. Additionally, you may evaluate how the addition of Imed Infinity to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes